Back to DA Darsana Capital Partners LP
NVCR
10 quarters
Position history for DADarsana Capital Partners LP's holdings in NovoCure Limited
No. Darsana Capital Partners exited its NVCR (NovoCure) position in Q1 2022. Its Q4 2021 13F listed 258,937 shares worth $19.4M. Darsana Capital Partners held NVCR in 9 quarterly 13F filings before exiting.
Final Value
$0
Final Shares
0
Total Value Change
-$113.8M
Total Shares Change
-1.4M
Quarter-by-Quarter History
Other major holders of NVCR: Capital World Investors, FMR LLC, Baillie Gifford & Co., Capital International Investors